To identify perioperative risk factors associated with postoperative pulmonary complications (PPCs) in bronchiectasis patients undergoing non-cardiothoracic surgery, emphasizing the importance of these factors for improving patient outcomes.
Key Findings:
PPCs incidence rates range from 2% to 40%, significantly impacting mortality and hospital stays, highlighting the need for targeted interventions.
Bronchiectasis patients have unique perioperative risks that have not been systematically studied in non-cardiothoracic surgery, indicating a gap in current research.
Preoperative respiratory microbiological status and pulmonary function tests are critical in assessing PPC risk, aligning with existing literature on respiratory complications.
Interpretation:
The study highlights the need for careful assessment of bronchiectasis patients undergoing non-cardiothoracic surgery due to their increased risk of PPCs.
Limitations:
Retrospective design may introduce selection bias and underreporting of variables, potentially affecting the reliability of the findings.
Microbiological testing was not routine for all patients, limiting comprehensive analysis and potentially overlooking significant risk factors.
Conclusion:
Identifying specific perioperative risk factors in bronchiectasis patients is essential for improving surgical outcomes and minimizing PPCs, underscoring the need for tailored preoperative assessments.
Post–cardiac arrest care is increasingly structured around survivorship, with standardized patient-reported assessments supporting multidisciplinary follow-up.